804 results about "Staphylococcus bacteria" patented technology

The invention belongs to the technical field of medicines, and particularly relates to application of sesquiterpenoids and / or pharmaceutically acceptable salts thereof in preparation of medicines for treating or preventing infectious diseases caused by staphylococcus aureus. The invention relates to the field of medicines, in particular to application in preparation of medicines for treating or preventing infectious diseases caused by drug-sensitive staphylococcus aureus or drug-resistant staphylococcus aureus. The structure of the sesquiterpenoids is shown as a formula I in the specification. The sesquiterpenoids applied in the invention are derived from rattan chrysanthemum, the source is wide, and the production cost is low. The sesquiterpenoids shown in the formula I have a very good activity inhibition effect on staphylococcus aureus for the first time, and the sesquiterpenoids have a very good activity inhibition effect on staphylococcus aureus with drug sensitivity, drug medium or drug resistance.

The invention discloses an antibacterial peptide based on D-type amino acid and application of the antibacterial peptide, and the antibacterial peptide is characterized in that the amino acid sequence is w-r-r-w-r-r-w-w-r-k-r (dTrp-dArg-dArg-dTrp-dArg-dArg-dTrp-dTrp-dArg-dLys-dArg). The antibacterial peptide can be synthesized through an Fmoc solid-phase chemical method, the synthesis difficulty is low, and the in-vivo antibacterial activity is good. The antibacterial peptide especially has broad-spectrum killing activity on carbapenem-resistant pseudomonas aeruginosa, pseudomonas aeruginosa, klebsiella pneumoniae, escherichia coli, methicillin-resistant staphylococcus aureus and staphylococcus aureus, is low in hemolytic toxicity, can reach half or more of cell survival rate under medium and low concentration, almost has no toxic effect on cells, and can be used for preparing the antibacterial peptide with a broad-spectrum killing activity on carbapenem-resistant pseudomonas aeruginosa, klebsiella pneumoniae, escherichia coli, methicillin-resistant staphylococcus aureus and staphylococcus aureus. The stability is good, the operability is high, and the cost is low.

The invention discloses preparation and application of an anti-staphylococcus aureus IsdB antibody. The antibody comprises a heavy chain variable region and a light chain variable region, the heavy chain variable region comprises HCDR1, HCDR2 and HCDR3 in the heavy chain variable region as shown in SEQ ID NO: 8; the light chain variable region comprises LCDR1, LCDR2 and LCDR3 in the light chain variable region as shown in SEQ ID NO: 16. The invention also provides nucleic acid for coding the antibody, a vector containing the nucleic acid and a cell containing the vector. In addition, experiments prove that the antibody can inhibit systemic infection of MRSA and resist invasion of MRSA to pneumonia, and has a good clinical application prospect.

The invention provides a thiazolidinone compound and application thereof in preparation of drugs for resisting staphylococcus aureus infection. The molecular structural formula of the thiazolidinone compound is shown as a formula (1), a formula (2), a formula (3) or a formula (4). The technical scheme of the invention discloses several thiazolidinone compounds, which not only have an excellent bactericidal effect on staphylococcus aureus and can significantly inhibit the formation of a biofilm of staphylococcus aureus, but also have low cytotoxicity and hemolytic activity. According to the technical scheme, a certain foundation is laid for research and development of novel staphylococcus aureus biofilm infection resisting drugs, and the potential of thiazolidone derivatives for developing novel antibacterial agents for staphylococcus aureus related infection can be deeply known possibly.

The invention relates to the technical field of biological medicine, in particular to an antibody aiming at staphylococcus aureus enterotoxin B and application thereof. A heavy chain variable region of the antibody provided by the invention comprises CDR sequences as shown in SEQ ID NO.1-3, and a light chain variable region of the antibody comprises CDR sequences as shown in SEQ ID NO.9-11. The antibody has high affinity, can specifically bind to staphylococcus aureus SEB, can block binding of SEB and MHC II / TCR, significantly inhibits cytokine storm, shows a dose-dependent protection effect in an MRSA systemic infection model, and can be used for preparing an MRSA systemic infection model. The monoclonal antibody can be used for treating, preventing or diagnosing the infection of the staphylococcus aureus, provides a solution of non-antibiotic therapy for SEB poisoning and drug-resistant staphylococcus aureus infection, and has important clinical and public health values.

The invention provides a kit for rapidly detecting MRSA and drug-resistant gene nucleic acid POCT of the MRSA based on a phage lyase mutant. The kit comprises nucleic acid extraction and purification and triple PCR rapid amplification detection reagents. The staphylococcus aureus bacteriophage lyase mutant nucleic acid release liquid containing the amino acid sequence as shown in SEQ ID NO: 1 is adopted, wall breaking can be rapidly conducted on staphylococcus aureus, and nucleic acid is released. The effect of the nucleic acid release liquid acting for 5 minutes is equivalent to or even better than that of the lysozyme acting for 60 minutes; according to the present invention, with the combination of the MRSA and drug-resistant gene triple PCR rapid amplification detection reagent, the total detection time is only 35 min, the time is saved by 55 min or more than 55 min compared with the lysozyme method, and the MRSA and drug-resistant gene nucleic acid POCT rapid detection can be achieved;

The invention discloses a staphylococcus aureus biosensor based on a nucleic acid aptamer and a preparation method of the staphylococcus aureus biosensor. Three fluorine atoms (F) are introduced into the 5'end, the 3 'end and the middle position of an aptamer 2' F3-(5 '3'm DNA) sequence (SEQ ID NO: 1) for modification, so that the binding force of the aptamer and graphene is remarkably enhanced, the signal stability and the anti-interference capability of the biosensor are remarkably improved, non-specific fluorescence leakage can be effectively blocked, and reliable guarantee is provided for complex sample detection. According to the present invention, with the cooperation of the graphene oxide quenching substrate, the high-sensitivity detection of the staphylococcus aureus is achieved, the detection limit of the sensor within 5 min can achieve 5 cells / mL, the sensitivity is high, the specificity on the complex sample is more than 95.4%, and the sensor is suitable for the food safety rapid screening and the clinical diagnosis.

The invention discloses an antibacterial peptide as well as a preparation method and application thereof. The antibacterial peptide has an amino acid sequence as shown in any one of SEQ ID NO: 1-11. The antibacterial peptide prepared by the scheme provided by the invention has very strong bacteriostasis and sterilization capabilities on methicillin-resistant staphylococcus aureus and multidrug-resistant escherichia coli, has application potential of becoming an antibacterial agent, a preservative or a disinfectant, and is not easy to generate drug resistance.

The invention belongs to the technical field of antibacterial peptides, and particularly relates to an LL-37 derived antibacterial peptide and application thereof. According to the invention, 17-29aa of the LL-37 antibacterial peptide is used as a core fragment and is connected with an amino acid sequence shown as SEQ ID NO: 1 or SEQ ID NO: 2 through an amido bond, the antibacterial activity of the obtained antibacterial peptide is obviously higher than that of the LL-37 antibacterial peptide, and the antibacterial peptide shows an obvious bactericidal effect on clinical drug-resistant bacteria such as acinetobacter baumannii, pseudomonas aeruginosa, escherichia coli, staphylococcus aureus, klebsiella pneumoniae and the like; meanwhile, the cytotoxicity and hemolytic activity are weak, drug resistance is not prone to being generated, bacteria can be rapidly killed in vivo through multiple mechanisms, no obvious cytotoxicity exists, the bacterium load in tissue is remarkably reduced, and the lifetime of a bacterium-infected mouse is prolonged.

The invention discloses marine-derived penicillium as well as a fermentation method and application thereof. The marine source penicillium is named as Penicillium sp.DSF059, and the preservation number of the marine source penicillium is CCTCC (China Center For Type Culture Collection) NO: M 20232310. According to the invention, the culture conditions of the strain are optimized, the culture medium and culture conditions with high yield of antibacterial active compounds are selected for fermentation, more target products can be obtained, the operation is simple, the cost is low, and the method is suitable for industrial production. Meanwhile, the marine-derived penicillium sp. DSF059 can provide an excellent strain for the development of new drugs for resisting plant pathogens such as coffee leaf blight, coffee brown spot, grape gray mold, golden cypress brown spot, citrus black rot, phytophthora capsici, hickory leaf blight and coffee black spot as well as four pathogens separated from coffee leaf diseases and staphylococcus aureus; good application prospects are realized on prevention and treatment of phytopathogen and staphylococcus aureus.

The invention discloses a salt-tolerant staphylococcus warneri strain WB224, and the preservation registration number of the salt-tolerant staphylococcus warneri strain WB224 is CGMCC No: 28260. The invention also discloses two applications of the strain WB224: 1, the strain WB224 is applied to thick broad-bean sauce flavored fermented foods (thick broad-bean sauce, chilli sauce and fermented soya beans); and 2, application in improvement of acid soil. The strain WB224 is obtained from a fermented food Pixian thick broad-bean sauce, the coagulase reaction is negative, the strain has the characteristics of strong stress resistance and high salt resistance, the formation of flavor substances such as esters and alcohols in the thick broad-bean sauce flavor fermented food can be obviously promoted, and the flavor of a product is effectively improved. Meanwhile, the acid soil with the pH value of 4.5-5.0 can be improved to a subacid environment with the pH value of 6.0-6.5; the effect is lasting and stable, and secondary pollution is avoided. The method has dual application values of food fermentation and soil improvement, so that the method has a wide industrial application prospect.

The invention belongs to the technical field of food processing, and particularly relates to fermented beef jerky and a preparation method thereof. The preparation method of the beef jerky comprises the following steps: (1) removing fascia and fat from fresh cattle hind leg meat, washing with clear water, and cutting into meat slices; (2) adding table salt, glucose, white granulated sugar and sodium nitrite into the sliced meat, uniformly mixing, adding a fermentation inoculant which comprises staphylococcus calcaratus, pediococcus acidilactici, bifidobacterium bifidum and Witzia ciliaris, and fermenting; and (3) after fermentation, drying and cooling to obtain the fermented beef jerky. Specific strains are selected to form a fermentation inoculant for fermentation, and the prepared fermented beef jerky is high in free amino acid and soluble peptide content, low in nitrite residual quantity, uniform red brown in color and slightly bright in surface, and belongs to high-quality beef jerky.

Method and kit for topical treatment of a skin infection, in particular of superficial skin infections, caused by Staphylococcus aureus. The method comprises the steps of applying a photosensitizer to at least a part of the skin affected by the infection, and subjecting said part of the skin to first photons with a majority energy between 2.8 eV and 3.5 eV at a first energy level; and second photons with a majority energy between 1.24 eV and 1.65 eV at a second energy level, the ratio between the first and the second energy levels being in the range from about 10:1 to 2:1. By the method efficient treatment of Staphylococcus aureus infections can be achieved without the administration of topical antibiotics.

The invention relates to a new endolysin and to its use for its anti-staphylococcal activity, in particular anti-staphylococcal activity against strains resistant to an antibiotic and / or to a phage, in particular anti-S. aureus and / or anti-S. pseudintermedius. It can therefore be used in a disinfectant or anti-biofilm solution, in food safety, in cosmetics or in therapies, for example in the treatment of pathologies caused by Staphylococcus such as skin pathologies in humans and domestic animals.

The invention relates to the technical field of PA resin, and particularly discloses glass fiber modified antibacterial PA resin suitable for children products and a preparation method of the antibacterial PA resin. The invention discloses glass fiber modified antibacterial PA resin suitable for children products. The glass fiber modified antibacterial PA resin comprises PA resin, glass fibers, talcum powder, nano calcium carbonate, a composite antibacterial agent, a compatilizer, an antioxidant and calcium stearate, the composite antibacterial agent comprises chitosan, an antibacterial peptide microcapsule and a porous silver-zinc-loaded antibacterial agent; the antibacterial peptide microcapsules are sodium alginate embedded antibacterial peptides. The antibacterial PA resin obtained in the invention has the highest bacteriostasis rates of 99.97%, 99.74% and 99.95% for staphylococcus aureus, escherichia coli and candida albicans respectively, the antibacterial property of the PA resin is improved, the compressive strength and notch impact strength are 170.6 MPa and 17.3 kJ / m < 2 > respectively, and high mechanical strength is maintained on the basis of high antibacterial property.

The invention relates to lactobacillus gasseri FMTA1121E with an effect of regulating a vaginal micro-ecological environment and application of the lactobacillus gasseri FMTA1121E. The lactobacillus gasseri FMTA1121E is classified and named as lactobacillus gasseri, and the preservation number of the lactobacillus gasseri FMTA1121E is CGMCC No.34962. The lactobacillus gasseri FMTA1121E can be metabolized to generate beneficial components such as lactic acid, gamma-aminobutyric acid and hydrogen peroxide so as to regulate the genital tract environment and improve the health degree; and the bacillus subtilis has excellent bacteriostasis and sterilization effects on various common vaginal pathogenic bacteria such as escherichia coli, staphylococcus aureus, gardnerella vaginalis, candida albicans, neisseria gonorrhoeae and the like. Therefore, the lactobacillus gasseri FMTA1121E strain can be applied to preparation of preparations for preventing and treating related genital tract diseases such as vaginitis.

The invention relates to an enzyme response antibacterial carbon dot and a preparation method and application thereof.The carbon dot takes a copper-doped carbon dot as a core and is covalently grafted with a hyaluronic acid shell layer through amidation reaction to form a composite nano material Cu-CDs (at) HA, specifically, soluble copper salt and folic acid are subjected to a hydrothermal reaction to obtain the copper-doped carbon dot, carboxyl is activated through EDC / NHS in a buffer system, and the carbon dot is prepared. And performing grafting reaction with hyaluronic acid to obtain a target product. The hyaluronidase-containing antibacterial composition can be specifically degraded and release antibacterial components under the action of hyaluronidase, shows good bacterial responsive bactericidal performance, has the minimum inhibitory concentrations of 8 g / mL and 16 g / mL for staphylococcus aureus and escherichia coli respectively, and has peroxidase-like activity and free radical scavenging capacity. The antibacterial carbon dots can be used for preparing intelligent wound dressings, antibacterial coatings and other biomedical materials, and have the advantages of responsive drug release, efficient antibacterial property and promotion of wound repair.

The invention belongs to the technical field of biomedicine and nano material electronics, and particularly relates to a low-voltage efficient sterilization electrode device based on local enhanced electric field treatment. According to the electrode device, vertically-oriented nanoneedles serve as a core functional layer, a nanoneedle array is arranged on a conductive substrate, the intensity of an electric field in a pinpoint area is amplified by multiple times through the lightning rod effect induced by the tips of the nanoneedles so as to achieve irreversible electroporation of a low-potential induced pathogen membrane, the length of the nanoneedles is 5-100 micrometers, and the length of the nanoneedles is 5-100 micrometers. The curvature radius of the needle tip is lt; and the sterilization device can realize nearly complete sterilization on escherichia coli and methicillin-resistant staphylococcus aureus within 5 minutes. The invention further provides a nanometer microneedle sterilization patch based on the local enhanced electric field, a self-power-supply or external-source-power-supply energy supply mode is adopted, and rapid sterilization of a wound can be achieved without medicine adding.

The invention belongs to the technical field of food packaging materials, and particularly relates to a preparation method and application of a chitosan-gelatin-tea polyphenol composite preservative film. The invention discloses a chitosan / gelatin / tea polyphenol composite membrane which is prepared by taking chitosan and gelatin as matrixes and tea polyphenol as an active additive through a film casting method. When the addition amount of the tea polyphenol is 1.5%, the comprehensive performance of the composite film is optimal, the ultraviolet light transmittance is as low as 0.113%, and the antibacterial rates on escherichia coli and staphylococcus aureus respectively reach 73.34% and 99.78%. When the strawberry preservative is applied to strawberry preservation, the mass loss rate is only 15.27% after 11 days, the sensory quality is well kept, and the shelf life is prolonged by 4 days. The composite film has excellent antibacterial and fresh-keeping performance, the raw materials are natural and degradable, and the composite film has wide application prospects in the field of fruit and vegetable fresh-keeping.

The invention discloses application of swertiflavin in preparation of a medicine for treating infectious pneumonia caused by methicillin-resistant staphylococcus aureus, and relates to the technical field of medicine. It is found for the first time that swertiflavin can significantly reduce the toxicity of staphylococcus aureus by inhibiting the activity of ClpP protein in MRSA. In addition, the swertiflavin shows a remarkable protection effect in the treatment of the MRSA infectious pneumonia. Specifically, the swertiflavin not only can relieve the injury degree of lung tissues, but also can reduce infiltration and aggregation of inflammatory cells in the lung. The discovery shows that the swertiflavin has potential application value in the field of anti-infection treatment. The invention provides a novel treatment strategy, namely, swertiflavin is used as an active ingredient for preparing the medicine for treating the staphylococcus aureus infectious pneumonia.

The invention discloses a novel bifidobacterium infantis strain and application of extracellular products of the novel bifidobacterium infantis strain in delaying skin aging and regulating skin micro-ecology, and bifidobacterium infantis is bifidobacterium infantis BSJM24L007 which is preserved in the China General Microbiological Culture Collection Center (CGMCC for short) and has the preservation number of CGMCC No.33258. The invention further discloses a preparation method of the novel bifidobacterium infantis strain and the application of the extracellular products of the novel bifidobacterium infantis strain. The bifidobacterium infantis extracellular product prepared by the invention has an ideal effect of delaying skin aging, enables the skin to be more compact and elastic, reduces the generation of wrinkles and maintains normal metabolism of the skin, has relatively high safety, can effectively reduce the skin infection problem caused by staphylococcus aureus and propionibacterium acnes, and has a good application prospect. Skin infection and inflammation are reduced, skin health is promoted, and skin micro-ecological balance is maintained. The requirements of a modern skin external preparation on functionality and safety are met.

The invention belongs to the technical field of functional textile materials, and discloses a modified spandex-based high-elastic antibacterial knitted fabric and a preparation method thereof.The fabric is of a double-layer composite knitted structure and comprises an inner high-elastic breathable layer and an outer antibacterial compact layer; the inner layer is formed by blending modified spandex yarns and modified viscose fibers, and the outer layer is formed by blending modified spandex yarns and superfine polyester fibers. The modified spandex yarn is prepared by introducing a hydrophilic antibacterial monomer compound into a spandex base material and matching with a cross-linking agent for graft modification, the hydrophilic antibacterial monomer compound is formed by compounding guanidyl acrylate and acryloyloxy eugenol, and stable fixation of antibacterial groups is achieved from the molecular level. Meanwhile, the molecular chain structure is regulated and controlled to keep high elasticity. The elongation at break of the fabric is greater than or equal to 300%, the elastic recovery rate is greater than or equal to 95%, and the antibacterial rate on escherichia coli and staphylococcus aureus is greater than or equal to 99%.

The invention discloses a preparation method of a high-toughness transparent plastic cup, and belongs to the technical field of plastic preparation, and the preparation method comprises the following steps: 1, preparing a modified elastomer toughening agent from 16.4-21.9% of an isosorbide-based plasticizer, 2.2-2.6% of polydimethylsiloxane, 1.5-2.2% of citric acid and the balance of polycaprolactone; 2, preparing a cinnamyl aldehyde bamboo pulp antibacterial reinforcing agent from 4.8 to 8.2 percent of cinnamyl aldehyde, 22 to 36 percent of bamboo pulp, 7.5 to 10.6 percent of bio-based 1, 3-propylene glycol (PO3G) and the balance of water; 3, weighing the cinnamyl aldehyde bamboo pulp antibacterial reinforcing agent, the modified elastomer toughening agent and polylactic acid to prepare high-toughness polylactic acid; and 4, preparing the high-toughness transparent plastic cup from the high-toughness polylactic acid. The high-toughness transparent plastic cup is prepared by compounding the modified elastomer flexibilizer, the cinnamyl aldehyde bamboo pulp antibacterial enhancer and the polylactic acid, and has the advantages of high strength, excellent toughness, good staphylococcus aureus inhibition effect, biodegradability and the like.

The invention discloses an S-type three-dimensional carbon nitride / copper sulfide nanosphere heterojunction as well as a preparation method and application thereof, and belongs to the field of antibacterial application of nano materials. The three-dimensional porous carbon nitride not only can increase photocatalytic active sites, but also can improve close contact with copper sulfide. The copper sulfide nanospheres and the three-dimensional porous nanosheets construct an S-shaped heterojunction, and efficient separation of photo-induced electrons and hole pairs can be driven under the action of a built-in electric field, band edge bending and coulomb force. The S-type three-dimensional carbon nitride / copper sulfide nanosphere heterojunction can generate more active oxygen species to inactivate bacteria through a photocatalysis-Fenton-like reaction; in addition, the photothermal effect of copper sulphide has a certain auxiliary sterilization effect. Under the conditions of visible light irradiation and trace hydrogen peroxide, the inactivation rates of the S-type three-dimensional carbon nitride / copper sulfide nanosphere heterojunction on staphylococcus aureus and escherichia coli are up to 99.5% and 99.7% respectively, and meanwhile, the S-type three-dimensional carbon nitride / copper sulfide nanosphere heterojunction has a remarkable treatment effect on wounds infected by staphylococcus aureus.

The invention discloses a production method of a cool-feeling antibacterial PA66 chinlon filament, and belongs to the technical field of chemical fiber manufacturing. According to the method, PA66 slices are used as raw materials and matched with jade cool-feeling master batches and a septol antibacterial oil agent (the effective component is OPHB), and the PA66 polyamide filament with the cool-feeling antibacterial effect is prepared through the process steps of slice and master batch mixing, melt spinning, side blowing cooling, oiling, drafting and winding and the like. The cool-feeling antibacterial PA66 chinlon filament produced by the invention not only has excellent physical properties (the fineness is 40-50 dtex, the breaking strength is greater than or equal to 3.5 cN / dtex, and the elongation at break is 36-46%), but also has long-acting antibacterial property (the antibacterial rate to escherichia coli and staphylococcus aureus is greater than or equal to 99%, and the antibacterial rate after 50 times of washing is still greater than or equal to 98%) and stable cool feeling (the cool feeling value Q-max is greater than or equal to 0.2 W / (m.K)), and is safe, non-toxic, environment-friendly, simple in process and low in cost. The method is suitable for the field of close-fitting textiles such as warp knitting, weft knitting and hosiery knitting, and the industrial applicability is high.

Provided herein are methods and systems for use in determining risk of a Staphylococcus infection, predicting efficacy of a Staphylococcus vaccine, and prognosing clinical outcomes on a subject exposed to Staphylococcus. Methods of treating subject identified as having or at risk of a Staphylococcus infection are further provided.

The invention relates to the isolation and characterisation of one or more aptamers against staphylococcal C-S lyase. The invention also provides aptamers, aptamer-conjugates, and minimal functional fragments thereof which may be used to inhibit the activity of said lyases and thereby inhibit Staphylococcus associated malodour.

The invention discloses a cascade catalytic enzyme MOF-919-GOx as well as a preparation method and application thereof, and relates to the technical field of nano-enzymes. According to the invention, MOF-919-GOx is synthesized by a glutaraldehyde loading method, and detection shows that the loading capacity of GOx in MOF-919 is 372.20 [mu] g / mg; when 2 mg / mL of MOF-919-GOx and 25 mM of glucose are added, the pH value of the environment can be reduced, hydroxyl radicals can be generated, and efficient peroxidase-like activity is achieved. The cascade catalytic enzyme MOF-919-GOx has a concentration-dependent inhibition effect on suspended porphyromonas gingivalis and staphylococcus aureus, and the concentration-dependent inhibition effect on the suspended porphyromonas gingivalis and staphylococcus aureus is achieved. When the concentration of the MOF-919-GOx is 0.25 mg / mL, the MOF-919-GOx can generate a remarkable removal effect on a biological membrane in a dog oral cavity artificial saliva environment, can be used for developing a dog oral cavity antibacterial material, and has application potential in the veterinary clinical field.

The present application relates to the technical field of nursing pad, in particular to a sanitary pad containing traditional Chinese medicine composition condensation fragrance burst beads and a preparation process thereof.The sanitary pad comprises, from bottom to top, an anti-sticking paper, a waterproof layer, an absorption layer, a composite layer and an anti-sticking paper; the composite layer is obtained by placing the traditional Chinese medicine composition condensation fragrance burst beads on the first fabric layer, covering the second fabric layer, and then bonding.The traditional Chinese medicine composition in the sanitary pad can effectively inhibit Candida albicans, Escherichia coli and Staphylococcus aureus; the essential oil added in the burst fragrance condensation beads can provide a pleasant fragrance, making the sanitary pad emit fragrance, and when prepared into a nursing pad, it can effectively cover the odor of the female genital area, and also improve the antibacterial effect of the sanitary pad, resulting in lower genital itching and odor.The sanitary pad can give the user a genital area without odor and itching, which is beneficial to the physiological health of women.

The present invention relates to the use of a combination of a saccharide and glycerol for skin protection against undesirable bacteria. The present invention is particularly useful in the formulation of compositions that act as prebiotics for commensal skin bacteria such as S. epidermidis to produce metabolites such as lactic acid, which, through the present invention, has been shown to inhibit the growth of undesirable bacteria such as E. coli and S. aureus, among others. The present invention is especially useful because it provides both short-term (i.e., rapid) and long-term (or sustained) protection.